Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belotecan and Ifosfamide in Extensive Disease Small Cell Lung Cancer
NCT01784107Phase 2Unknown
- Sponsor
- Gachon University Gil Medical Center
- Start
- Jul 2011
- Primary completion
- Jul 2018
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of belotecan in small cell lung cancer (SCLC), sponsored by Gachon University Gil Medical Center. Status: unknown.
02
Drugs
belotecan
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT01784107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01784107.